146 related articles for article (PubMed ID: 2660896)
1. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.
Combaret V; Favrot MC; Kremens B; Philip I; Bailly C; Fontaniere B; Gentilhomme O; Chauvin F; Zucker JM; Bernard JL
Br J Cancer; 1989 Jun; 59(6):844-7. PubMed ID: 2660896
[TBL] [Abstract][Full Text] [Related]
2. [The significance of immunological analysis for the detection of residual neuroblasts in bone marrow].
Maritaz O; Combaret V; Favrot MC
Pathol Biol (Paris); 1988 Jan; 36(1):21-4. PubMed ID: 3283668
[TBL] [Abstract][Full Text] [Related]
3. Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
Favrot MC; Frappaz D; Maritaz O; Philip I; Fontaniere B; Gentilhomme O; Bailly C; Zucker JM; Gentet JC; Kemshead J
Br J Cancer; 1986 Oct; 54(4):637-41. PubMed ID: 3535865
[TBL] [Abstract][Full Text] [Related]
4. S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft.
Combaret V; Kremens B; Favrot MC; Laurent JC; Philip T
Bone Marrow Transplant; 1988 May; 3(3):221-7. PubMed ID: 2844344
[TBL] [Abstract][Full Text] [Related]
5. [Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations].
Frappaz D; Maritaz O; Favrot MC; Philip I; Bernard JL; Bailly C; Gentilhomme O; Gentet JC; Zucker JM; Bouffet E
Arch Fr Pediatr; 1987 Nov; 44(9):771-8. PubMed ID: 3446068
[TBL] [Abstract][Full Text] [Related]
6. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.
Franklin IM; Pritchard J
J Clin Pathol; 1983 Nov; 36(11):1215-8. PubMed ID: 6630571
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.
Rogers DW; Treleaven JG; Kemshead JT; Pritchard J
J Clin Pathol; 1989 Apr; 42(4):422-6. PubMed ID: 2654192
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal disease in bone marrow of neuroblastoma patients by immunofluorescence.
Berthold F; Schneider A; Schumacher R; Bosslet K
Pediatr Hematol Oncol; 1989; 6(2):73-83. PubMed ID: 2702075
[TBL] [Abstract][Full Text] [Related]
9. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
Matthay KK; Atkinson JB; Stram DO; Selch M; Reynolds CP; Seeger RC
J Clin Oncol; 1993 Nov; 11(11):2226-33. PubMed ID: 8229138
[TBL] [Abstract][Full Text] [Related]
10. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation.
Saarinen UM; Wikström S; Mäkipernaa A; Lanning M; Perkkiö M; Hovi L; Rapola J; Sariola H
J Clin Oncol; 1996 Oct; 14(10):2791-802. PubMed ID: 8874341
[TBL] [Abstract][Full Text] [Related]
11. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies.
Sugimoto T; Sawada T; Matsumura T; Kemshead JT; Horii Y; Saida T; Imashuku S; Takeuchi Y
Med Pediatr Oncol; 1988; 16(3):190-6. PubMed ID: 3288854
[TBL] [Abstract][Full Text] [Related]
13. Immunological detection and definition of minimal residual neuroblastoma disease in bone marrow samples obtained during or after therapy.
Gussetis ES; Ebener U; Wehner S; Kornhuber B
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1745-53. PubMed ID: 2698803
[TBL] [Abstract][Full Text] [Related]
14. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
[TBL] [Abstract][Full Text] [Related]
15. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.
Kemshead JT; Heath L; Gibson FM; Katz F; Richmond F; Treleaven J; Ugelstad J
Br J Cancer; 1986 Nov; 54(5):771-8. PubMed ID: 3542005
[TBL] [Abstract][Full Text] [Related]
16. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
Cheung NK; Von Hoff DD; Strandjord SE; Coccia PF
J Clin Oncol; 1986 Mar; 4(3):363-9. PubMed ID: 3081691
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples.
Beck D; Maritaz O; Gross N; Favrot M; Vultier N; Bailly C; Villa I; Gentilhomme O; Philip T
Eur J Pediatr; 1988 Aug; 147(6):609-12. PubMed ID: 3053190
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
[TBL] [Abstract][Full Text] [Related]
20. [Autologous bone marrow transplantation in children--experience with neuroblastoma].
Storm-Mathisen I; Glomstein A; Lie SO; Albrechtsen D; Monclair T; Kvalheim G; Jacobsen AB
Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2513-6. PubMed ID: 2219008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
